BSE Live
Dec 31, 16:01Prev. Close
6425.50
Open Price
6490.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:59Prev. Close
6360.50
Open Price
6499.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
6392.50 (110)
| Profit & Loss account of Divis Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 937.20 | 1,201.07 | 1,043.29 | 737.21 | 390.05 | |
| Less: Excise/Sevice Tax/Other Levies | 5.57 | 7.71 | 7.90 | 4.33 | 4.48 | |
| Revenue From Operations [Net] | 931.63 | 1,193.35 | 1,035.39 | 732.88 | 385.57 | |
| Total Operating Revenues | 931.63 | 1,193.35 | 1,035.39 | 732.88 | 385.57 | |
| Other Income | 28.47 | -10.43 | 1.53 | 4.53 | 4.46 | |
| Total Revenue | 960.10 | 1,182.92 | 1,036.92 | 737.41 | 390.03 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 455.20 | 607.74 | 496.70 | 345.41 | 208.82 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 10.31 | 10.35 | 10.47 | 8.51 | 6.22 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -99.07 | -98.54 | -32.16 | 12.96 | -13.10 | |
| Employee Benefit Expenses | 95.16 | 92.75 | 73.45 | 46.29 | 25.42 | |
| Finance Costs | 1.19 | 4.01 | 8.20 | 8.88 | 4.34 | |
| Depreciation And Amortisation Expenses | 51.45 | 47.82 | 35.65 | 22.33 | 14.82 | |
| Other Expenses | 57.42 | 60.45 | 59.91 | 66.33 | 36.61 | |
| Total Expenses | 571.65 | 724.58 | 652.23 | 510.71 | 283.12 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 388.45 | 458.34 | 384.69 | 226.70 | 106.91 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 388.45 | 458.34 | 384.69 | 226.70 | 106.91 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 40.80 | 26.61 | 17.45 | 33.16 | 33.60 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 3.34 | 7.27 | 11.77 | 1.37 | 3.13 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 44.14 | 34.09 | 29.54 | 34.79 | 36.88 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 344.31 | 424.25 | 355.15 | 191.91 | 70.03 | |
| Profit/Loss From Continuing Operations | 344.20 | 424.41 | 353.56 | 191.75 | 70.47 | |
| Profit/Loss For The Period | 344.20 | 424.41 | 353.56 | 191.75 | 70.47 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 26.05 | 65.54 | 54.77 | 148.51 | 54.98 | |
| Diluted EPS (Rs.) | 26.05 | 65.54 | 54.77 | 148.51 | 54.98 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 153.76 | 247.08 | 184.06 | 138.49 | 64.18 | |
| Indigenous Raw Materials | 241.44 | 295.56 | 259.83 | 172.63 | 118.74 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 79.29 | 38.91 | 25.82 | 12.91 | 12.82 | |
| Tax On Dividend | 13.17 | 6.62 | 4.39 | 1.81 | 1.80 | |
| Equity Dividend Rate (%) | 300.00 | 300.00 | 200.00 | 100.00 | 100.00 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill